Table 1.
Patient no. | Age (mo) | Sex | Parasitaemia (Pf) &/or Organism cultured | Admitting coma score | Coma duration Before/After admission (h) | Brain vessel iNOS (n) | Brain vessel MIF (n) | Parasites in brain vessels | Chest Wall vessel iNOS | Chest Wall vessel MIF | Chest Wall muscle iNOS |
4 | 20 | M | 18.6% | 2 | missing/6 | 0-1+ (6) | 0 (3) | 1+ | 0-1+ | 4+ | 2+ |
7 | 29 | F | 4+ | 0 | 1/1 | 0-1+ (6) | 0 (3) | 1+ | 0-1+ | 3+ | 4+ |
31 | 39 | M | 49% | 1 | 7/22 | 0-1+ (9) | 0 (3) | 1+ | 0-1+ | 3+ | 0-1+ |
33 | 25 | M | 0.26% | 0 | 2/15 | 0-1+ (8) | 0 (3) | 1+ | 2+ | 2+ | 0-1+ |
37 | 6 | M | 34% ¶ mal. trace | 2 | missing/14 | 0-1+ (9) | 0 (3) | 1+ | 3+ | 3+ | 3+ |
47 | 22 | F | 11% | 1 | 6/44 | 0-1+ (13) | 0 (3) | 1+ | 0-1+ | 3+ | 0-1+ |
49 | 17 | M | 0.09% | 1 | 2/34 | 0-1+ (12) | 0 (3) | 1+ | 2+ | 3+ | 4+ |
22 | 18 | M | 1.75% | 0 | 1/3 | 2+ (8) | 0 (3) | 1+ | 3+ | ND | 2+ |
38 | 84 | F | 22% | 0 | 5/35 | 2+ (9) | 0 (3) | 1+ | 0-1+ | 2+ | 0-1+ |
45 | 34 | M | 2.5% | 0 | 8/28 | 2+ (13) | 0 (3) | 1+ | 0-1+ | 3+ | 0-1+ |
23 | 30 | F | 29% | 0 | 5/7 | 3+ (9) | 0 (3) | 1+ | 3+ | 3+ | 0-1+ |
CM(B), sequestered parasites only | |||||||||||
5 | 14 | M | 3.5% | 1 | NA/18 | 0-1+ (3) | 0 (3) | 4+ | 4+ | 3+ | 4+ |
21 | 25 | F | 0.33% | 2 | 2/12 | 0-1+ (3) | 0 (3) | 4+ | 4+ | 4+ | 4+ |
16 | 51 | F | 5.5% | 1 | 22/6 | 0-1+ (3) | 0 (3) | 2+ | 2+ | 4+ | 2+ |
39 | 18 | M | 0.27% | 2 | 6/18 | 0-1+ (9) | 0 (3) | 4+ | 2+ | 3+ | 2+ |
42 | 37 | F | 20% | 0 | missing | 0-1+ (11) | 0 (3) | 4+ | 3+ | 4+ | 2+ |
25 | 44 | F | 0.02% | 2 | 1/11 | 2+ (8) | 0 (3) | 4+ | 3+ | 3+ | 0-1+ |
1 | 27 | F | 31.1% | 0 | 7/18 | 3+ (3) | 0 (3) | 2+ | 2+ | ND | 2+ |
CM(C), sequestered parasites plus local intravascular inflammation | |||||||||||
13 | 22 | M | 36.52% | 0-1 | 15/1 | 0-1+ (3) | 0 (3) | 3+ | 2+ | 2+ | 2+ |
27 | 20 | M | 53.4% & Sal. typhi-m | 0 | missing/3 | 2+ (3) | 0 (3) | 3+ | 4+ | 3+ | 0-1+ |
28 | 61 | F | 23.6% | 0 | 12/0 | 2+ (9) | 0 (3) | 2+ | 0-1+ | 2+ | 0-1+ |
29 | 43 | M | 33% | 2 | 18/11 | 3+ (9) | 0 (3) | 3+ | 0-1+ | 3+ | 0-1+ |
32 | 18 | F | 47% | 0 | 24/3 | 3+ (9) | 0 (3) | 3+ | 0-1+ | 4+ | 0-1+ |
34 | 70 | M | 2.4% | 1 | 36/3 | 3+ (9) | 0 (3) | 4+ | 3+ | 3+ | 2+ |
35 | 114 | M | 0.21% | 1 | 12/15 | 3+ (9) | 0 (3) | 3+ | 2+ | 2+ | 2+ |
36 | 21 | F | 0.88% | 2 | 3/10 | 3+ (8) | 0 (3) | 2+ | 3+ | 3+ | 3+ |
48 | 48 | M | 0.03% | 2 | 4/22 | 3+ (13) | 0 (3) | 3+ | 2+ | 2+ | 3+ |
6 | 17 | F | 5.8% | 0 | 19/1 | 4+ (9) | 0 (3) | 3+ | 4+ | 3+ | 4+ |
9 | 16 | M | 0.03% | 1 | 11/23 | 4+ (3) | 0 (3) | 3+ | 3+ | 3+ | 4+ |
11 | 29 | F | 29.5% & H. influ. B | 1 | 28/30 | 4+ (3) | 0 (3) | 2+ | 4+ | 4+ | 4+ |
15 | 8 | F | 0.94% | 2 | 8/15 | 4+ (3) | 0 (3) | 2+ | 3+ | 2+ | 3+ |
26 | 30 | M | 19% | 1 | 1/31 | 4+ (9) | 0 (3) | 4+ | 4+ | 4+ | missing |
COMA (clinically judged not cerebral malaria) | |||||||||||
* 8 | 41 | F | negative | 3 | 3/9 | 3+ (3) | 0 (3) | negative | 0-1+ | 4+ | 0-1+ |
10 | 66 | F | 0.01% | 0 | 5/4 | 0-1+ (3) | 0 (3) | negative | 2+ | 0-1+ | 2+ |
12 | 6 | M | Sal. enteritidis | 2 | 1/4 | 0-1+ (3) | 0 (3) | negative | 2+ | 4+ | 2+ |
14 | 9 | F | E. coli | 0 | missing | 0-1+ (3) | 0 (3) | negative | 4+ | 4+ | 4+ |
17 | 51 | F | negative | 0 | 2/9 | 0-1+ (3) | 0 (3) | negative | 0-1+ | 0-1+ | 0-1+ |
18 | 7 | F | H. influenzae B | 1 | 48/14 | 0-1+ (3) | 0 (3) | negative | 3+ | 3+ | 4+ |
20 | 96 | F | Tuberculosis | 0 | missing | 0-1+ (3) | 0 (3) | negative | 4+ | 2+ | 0-1+ |
24 | 48 | F | Strep. pneumoniae | 3 | missing | 0-1+ (3) | 0 (3) | negative | 2+ | 4+ | 2+ |
40 | 26 | F | 0.02% | 1 | 24/63 | 2+ (9) | 0 (3) | negative | 0-1+ | 4+ | 2+ |
44 | 21 | F | negligible | 1 | 7/3 | 0-1+ (13) | 0 (3) | negative | 2+ | 2+ | 2+ |
MALAWIAN CONTROLS (without terminal coma) | |||||||||||
41 | 29 | F | Sal. typhimurium | 5 | NA/NA | 0-1+ (13) | 0 (3) | negative | 0-1+ | 0-1+ | 0-1+ |
* 50 | 144 | F | Strep. pneumoniae | 5 | NA/NA | 0-1+ (13) | 0 (3) | negative | 0-1+ | 3+ | 0-1+ |
AUSTRALIAN CONTROLS | |||||||||||
n = 5 | F/M | NA | NA | NA/NA | NA | NA | negative | 0-1+ | 0-1+ | 0-1+ | |
n = 7 | F/M | NA | 5 | NA/NA | 0-1+ (3) | 0 (3 ea) | negative | NA | NA | NA |
* Serologically positive for HIV (n) Number of brains areas examined ND = not done NA = not applicable